무균 주사제 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)
Sterile Injectable Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
상품코드:1585080
리서치사:Persistence Market Research
발행일:2024년 11월
페이지 정보:영문 249 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
이 보고서는 세계 무균 주사제 시장을 조사 분석하여 시장 촉진요인, 동향, 기회, 촉진요인, 과제 등 주요 시장 역학에 대한 평가와 시장 구조에 대한 자세한 인사이트를 제공합니다.
목차
제1장 주요 요약
제2장 시장 소개
제3장 세계의 무균 주사제 시장 분석 시나리오
시장과 예측
시장 규모와 전년비 성장
시장 개요
밸류체인
제4장 시장 역학
거시경제 요인
성장 촉진요인
공급측
수요측
성장 억제요인
기회
예측요인 - 관련성과 영향
특허 유효기간
제5장 세계의 무균 주사제 시장 분석과 예측 : 분자별
소개
BPS(Basis Point Share) 분석 : 분자 유형별
전년비 성장 예측 : 분자 유형별
시장 금액 예측 : 분자별
고분자
저분자
시장 매력 : 분자별
제6장 세계의 무균 주사제 시장 분석과 예측 : 약제별
소개
BPS(Basis Point Share) 분석 : 약제별
전년비 성장 예측 : 약제별
시장 금액 예측 : 약제별
단클론항체(Mabs)
사이토카인
인슐린
펩타이드 호르몬
백신
면역글로불린
혈액인자
펩타이드 항생제
기타
시장 매력 : 약제별
제7장 세계의 무균 주사제 시장 분석과 예측 : 용도별
소개
BPS(Basis Point Share) 분석 : 용도별
전년비 성장 예측 : 용도별
시장 금액 예측 : 용도별
암
당뇨병
심혈관질환
근골격
중추신경계
감염증
기타
시장 매력 : 용도별
제8장 세계의 무균 주사제 시장 분석과 예측 : 투여 경로별
소개
BPS(Basis Point Share) 분석 : 투여 경로별
전년비 성장 예측 : 투여 경로별
시장 금액 예측 : 투여 경로별
정맥내(IV)
근육내(IM)
피하(SC)
기타
시장 매력 : 투여 경로별
제9장 세계의 무균 주사제 시장 분석과 예측 : 유통 채널별
소개
BPS(Basis Point Share) 분석 : 유통 채널별
전년비 성장 예측 : 유통 채널별
시장 금액 예측 : 유통 채널별
병원 약국
소매 약국
온라인 약국
시장 매력 : 유통 채널별
제10장 세계의 무균 주사제 시장 분석과 예측 : 지역별
BPS(Basis Point Share) 분석 : 지역별
전년비 성장 예측 : 지역별
시장 금액 예측 : 지역별
북미
라틴아메리카
유럽
아시아태평양
중동 및 아프리카
시장 매력 : 지역별
제11장 북미의 무균 주사제 시장 분석과 예측
소개
BPS(Basis Point Share) 분석 : 국가별
전년비 성장 예측 : 국가별
시장 금액 예측 : 분자별
고분자
저분자
시장 금액 예측 : 유통 채널별
병원 약국
소매 약국
온라인 약국
시장 금액 예측 : 약제별
단클론항체(Mabs)
사이토카인
인슐린
펩타이드 호르몬
백신
면역글로불린
혈액인자
펩타이드 항생제
기타
시장 금액 예측 : 용도별
암
당뇨병
심혈관질환
근골격
중추신경계
감염증
기타
시장 금액 예측 : 투여 경로별
정맥내(IV)
근육내(IM)
피하(SC)
기타
시장 금액 예측 : 국가별
미국
캐나다
시장 매력 분석
분자별
유통 채널별
약제별
용도별
투여 경로별
국가별
주목할 만한 동향
제12장 라틴아메리카의 무균 주사제 시장 분석과 예측
소개
BPS(Basis Point Share) 분석 : 국가별
전년비 성장 예측 : 국가별
시장 금액 예측 : 분자별
고분자
저분자
시장 금액 예측 : 유통 채널별
병원 약국
소매 약국
온라인 약국
시장 금액 예측 : 약제별
단클론항체(Mabs)
사이토카인
인슐린
펩타이드 호르몬
백신
면역글로불린
혈액인자
펩타이드 항생제
기타
시장 금액 예측 : 용도별
암
당뇨병
심혈관질환
근골격
중추신경계
감염증
기타
시장 금액 예측 : 투여 경로별
정맥내(IV)
근육내(IM)
피하(SC)
기타
시장 금액 예측 : 국가별
브라질
멕시코
기타 라틴아메리카
시장 매력 분석
분자별
유통 채널별
약제별
용도별
투여 경로별
국가별
주목할 만한 동향
제13장 유럽의 무균 주사제 시장 분석과 예측
소개
BPS(Basis Point Share) 분석 : 국가별
전년비 성장 예측 : 국가별
시장 금액 예측 : 분자별
고분자
저분자
시장 금액 예측 : 유통 채널별
병원 약국
소매 약국
온라인 약국
시장 금액 예측 : 약제별
단클론항체(Mabs)
사이토카인
인슐린
펩타이드 호르몬
백신
면역글로불린
혈액인자
펩타이드 항생제
기타
시장 금액 예측 : 용도별
암
당뇨병
심혈관질환
근골격
중추신경계
감염증
기타
시장 금액 예측 : 투여 경로별
정맥내(IV)
근육내(IM)
피하(SC)
기타
시장 금액 예측 : 국가별
영국
프랑스
독일
이탈리아
스페인
러시아
기타 유럽
시장 매력 분석
분자별
유통 채널별
약제별
용도별
투여 경로별
국가별
주목할 만한 동향
제14장 APEJ 무균 주사제 시장 분석과 예측
소개
BPS(Basis Point Share) 분석 : 국가별
전년비 성장 예측 : 국가별
시장 금액 예측 : 분자별
고분자
저분자
시장 금액 예측 : 유통 채널별
병원 약국
소매 약국
온라인 약국
시장 금액 예측 : 약제별
단클론항체(Mabs)
사이토카인
인슐린
펩타이드 호르몬
백신
면역글로불린
혈액인자
펩타이드 항생제
기타
시장 금액 예측 : 용도별
암
당뇨병
심혈관질환
근골격
중추신경계
감염증
기타
시장 금액 예측 : 투여 경로별
정맥내(IV)
근육내(IM)
피하(SC)
기타
시장 금액 예측 : 국가별
일본
중국
인도
호주·뉴질랜드
ASEAN
기타 아시아태평양
시장 매력 분석
분자별
유통 채널별
약제별
용도별
투여 경로별
국가별
주목할 만한 동향
제15장 중동 및 아프리카의 무균 주사제 시장 분석과 예측
소개
BPS(Basis Point Share) 분석 : 국가별
전년비 성장 예측 : 국가별
시장 금액 예측 : 분자별
고분자
저분자
시장 금액 예측 : 유통 채널별
병원 약국
소매 약국
온라인 약국
시장 금액 예측 : 약제별
단클론항체(Mabs)
사이토카인
인슐린
펩타이드 호르몬
백신
면역글로불린
혈액인자
펩타이드 항생제
기타
시장 금액 예측 : 용도별
암
당뇨병
심혈관질환
근골격
중추신경계
감염증
기타
시장 금액 예측 : 투여 경로별
정맥내(IV)
근육내(IM)
피하(SC)
기타
시장 금액 예측 : 국가별
GCC 국가
남아프리카공화국
북아프리카
기타 중동 및 아프리카
시장 매력 분석
분자별
유통 채널별
약제별
용도별
투여 경로별
국가별
주목할 만한 동향
제16장 경쟁 상황
경쟁 대시보드
기업 개요(상세 - 개요, 재무, 전략, 최근의 동향)
Baxter International Inc.
Sanofi
Pfizer Inc.
GlaxoSmithKline plc.
AstraZeneca
GILEAD SCIENCES, INC.
Merck & Co., Inc.
Novartis AG
Johnson & Johnson Services, Inc.
Nova Nordisk A/S
제17장 사용되는 가정과 두문자어
제18장 조사 방법
ksm
영문 목차
영문목차
Persistence Market Research has recently released an in-depth report on the global Sterile Injectable Drugs Market, providing a thorough analysis of key market dynamics, including driving factors, trends, opportunities, and challenges. This detailed report provides valuable insights into the market landscape, helping stakeholders make informed decisions on investment and strategy.
Global Market Growth Rate (CAGR 2024 to 2032): 6.7%
Sterile Injectable Drugs Market - Report Scope:
The global Sterile Injectable Drugs Market encompasses a wide range of injectable products, primarily aimed at treating various chronic diseases, including cancer, diabetes, and cardiovascular conditions. The market is driven by the increasing prevalence of cancer and chronic illnesses worldwide, alongside the growing demand for advanced treatment options. The sector is marked by rapid advancements in drug development, particularly for oncology applications, and a heightened focus on injectable formats due to their efficacy in drug delivery.
Market Growth Drivers:
Several factors are fueling the growth of the global Sterile Injectable Drugs Market. The rising incidence of cancer and chronic diseases is significantly boosting demand for injectable anti-cancer drugs. Additionally, the growing number of drug manufacturers focusing on oncology treatments and the swift FDA approval process for sterile injectable drugs are enhancing market accessibility and supply. The convenience and effectiveness of injectable drug delivery systems further contribute to this market's expansion.
Market Restraints:
Despite its robust growth, the Sterile Injectable Drugs Market faces several challenges. High operational costs associated with the manufacturing of sterile drugs, including the requirement for complex equipment and stringent regulatory compliance, are major hindrances. The discontinuation of certain injectable products due to high production costs and competition from low-cost manufacturers is also affecting revenue growth. Moreover, the consolidation of supply chains by large pharmaceutical companies has led to the closure of manufacturing sites, negatively impacting the cancer segment.
Market Opportunities:
The Sterile Injectable Drugs Market presents significant growth opportunities, particularly in the oncology segment. The demand for injectable oncology drugs is expected to rise sharply, especially in regions like Europe and North America, where healthcare access and drug availability are improving. Expanding market presence in emerging economies and leveraging e-commerce distribution channels will also create new avenues for growth. Collaborative partnerships between pharmaceutical companies and healthcare providers will be crucial for meeting the rising demand for sterile injectable drugs.
Key Questions Answered in the Report:
What factors are driving global growth in the Sterile Injectable Drugs Market?
Which regions and segments are experiencing the highest demand for injectable drugs?
How are trends in oncology treatments and drug innovations influencing the competitive landscape of the market?
Who are the major players in the Sterile Injectable Drugs Market, and what strategies are they employing to maintain a competitive edge?
What are the emerging trends and future projections for the Sterile Injectable Drugs Market?
Competitive Intelligence and Business Strategy:
Key players in the global Sterile Injectable Drugs Market, including Amgen Inc., Pfizer Inc., and Roche Holding AG, are focusing on product innovation and expanding their manufacturing capabilities to enhance market share. Investments in research and development for new drug formulations and delivery methods are priorities for these companies. Strategic partnerships and acquisitions are also vital for improving geographic presence and operational efficiency in this highly competitive market.
Key Companies Profiled:
Baxter International Inc.
Sanofi
Pfizer Inc.
GlaxoSmithKline plc.
AstraZeneca
GILEAD SCIENCES, INC.
Merck & Co., Inc.
Novartis AG
Johnson & Johnson Services, Inc.
Nova Nordisk A/S
Others
Sterile Injectable Drugs Market Segmentation:
By Drug Type:
Monoclonal Antibodies
Cytokines
Insulin
Peptide Hormones
Blood Factors
Vaccines
Immunoglobulins
Peptide Antibiotics
Others
By Application:
Cancer
Diabetes
Cardiovascular Diseases
Musculoskeletal
CNS
Infections
Others
By Route of Administration:
Intravenous (IV)
Intramuscular (IM)
Subcutaneous (SC)
Others
By Molecule Type:
Small Molecules
Large Molecules
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:
North America
Latin America
Europe
Asia Pacific
Middle East & Africa
Table of Contents
1. Executive Summary
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Global Sterile Injectable Drugs Market Analysis Scenario
3.1. Market Size (US$ Mn) and Forecast
3.1.1. Market Size and Y-o-Y Growth
3.1.2. Absolute $ Opportunity
3.2. Market Overview
3.2.1. Value Chain
4. Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
4.5. Forecast Factors - Relevance and Impact
4.6. Patent Expiries
5. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Molecules
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Molecules Type
5.3. Y-o-Y Growth Projections By Molecules Type
5.4. Market Value Forecast By Molecules, 2024-2033
5.4.1. Large Molecules
5.4.2. Small Molecules
5.5. Market Attractiveness By Molecules
6. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Drugs
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By Drugs
6.3. Y-o-Y Growth Projections By Drugs
6.4. Market Value Forecast By Drugs , 2024-2033
6.4.1. Monoclonal Antibodies (Mabs)
6.4.2. Cytokines
6.4.3. Insulin
6.4.4. Peptide Hormones
6.4.5. Vaccines
6.4.6. Immunoglobulins
6.4.7. Blood Factors
6.4.8. Peptide Antibiotics
6.4.9. Others
6.5. Market Attractiveness By Drugs
7. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Application
7.1. Introduction
7.2. Basis Point Share (BPS) Analysis By Application
7.3. Y-o-Y Growth Projections By Application
7.4. Market Value Forecast By Application, 2024-2033
7.4.1. Cancer
7.4.2. Diabetes
7.4.3. Cardiovascular Diseases
7.4.4. Musculoskeletal
7.4.5. CNS
7.4.6. Infections
7.4.7. Others
7.5. Market Attractiveness By Application
8. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Route of Administration
8.1. Introduction
8.2. Basis Point Share (BPS) Analysis By Route of Administration
8.3. Y-o-Y Growth Projections By Route of Administration
8.4. Market Value Forecast By Route of Administration, 2024-2033
8.4.1. Intravenous (IV)
8.4.2. Intramuscular (IM)
8.4.3. Subcutaneous (SC)
8.4.4. Others
8.5. Market Attractiveness By Route of Administration
9. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Distribution Channel
9.1. Introduction
9.2. Basis Point Share (BPS) Analysis By Distribution Channel
9.3. Y-o-Y Growth Projections By Distribution Channel
9.4. Market Value Forecast By Distribution Channel , 2019-2024
9.4.1. Hospitals Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Market Attractiveness By Distribution Channel
10. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Region
10.1. Basis Point Share (BPS) Analysis By Region
10.2. Y-o-Y Growth Projections By Region
10.3. Market Value Forecast By Region
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. APEJ
10.3.5. MEA
10.4. Market Attractiveness By Region
11. North America Sterile Injectable Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis By Country
11.1.2. Y-o-Y Growth Projections By Country
11.2. Market Value Forecast By Molecules, 2024-2033
11.2.1. Large Molecules
11.2.2. Small Molecules
11.3. Market Value Forecast By Distribution Channel , 2024-2033
11.3.1. Hospitals Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Online Pharmacies
11.4. Market Value Forecast By Drugs , 2024-2033
11.4.1. Monoclonal Antibodies (Mabs)
11.4.2. Cytokines
11.4.3. Insulin
11.4.4. Peptide Hormones
11.4.5. Vaccines
11.4.6. Immunoglobulins
11.4.7. Blood Factors
11.4.8. Peptide Antibiotics
11.4.9. Others
11.5. Market Value Forecast By Application, 2024-2033
11.5.1. Cancer
11.5.2. Diabetes
11.5.3. Cardiovascular Diseases
11.5.4. Musculoskeletal
11.5.5. CNS
11.5.6. Infections
11.5.7. Others
11.6. Market Value Forecast By Route of Administration, 2024-2033
11.6.1. Intravenous (IV)
11.6.2. Intramuscular (IM)
11.6.3. Subcutaneous (SC)
11.6.4. Others
11.7. Market Value Forecast By Country, 2024-2033
11.7.1. US
11.7.2. Canada
11.8. Market Attractiveness Analysis
11.8.1. By Molecules
11.8.2. By Distribution Channel
11.8.3. By Drugs
11.8.4. By Application
11.8.5. By Route of Administration
11.8.6. By Country
11.9. Prominent Trends
12. Latin America Sterile Injectable Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis By Country
12.1.2. Y-o-Y Growth Projections By Country
12.2. Market Value Forecast By Molecules, 2024-2033
12.2.1. Large Molecules
12.2.2. Small Molecules
12.3. Market Value Forecast By Distribution Channel , 2024-2033
12.3.1. Hospitals Pharmacies
12.3.2. Retail Pharmacies
12.3.3. Online Pharmacies
12.4. Market Value Forecast By Drugs , 2024-2033
12.4.1. Monoclonal Antibodies (Mabs)
12.4.2. Cytokines
12.4.3. Insulin
12.4.4. Peptide Hormones
12.4.5. Vaccines
12.4.6. Immunoglobulins
12.4.7. Blood Factors
12.4.8. Peptide Antibiotics
12.4.9. Others
12.5. Market Value Forecast By Application, 2024-2033
12.5.1. Cancer
12.5.2. Diabetes
12.5.3. Cardiovascular Diseases
12.5.4. Musculoskeletal
12.5.5. CNS
12.5.6. Infections
12.5.7. Others
12.6. Market Value Forecast By Route of Administration, 2024-2033
12.6.1. Intravenous (IV)
12.6.2. Intramuscular (IM)
12.6.3. Subcutaneous (SC)
12.6.4. Others
12.7. Market Value Forecast By Country, 2024-2033
12.7.1. Brazil
12.7.2. Mexico
12.7.3. Rest of Latin America
12.8. Market Attractiveness Analysis
12.8.1. By Molecules
12.8.2. By Distribution Channel
12.8.3. By Drugs
12.8.4. By Application
12.8.5. By Route of Administration
12.8.6. By Country
12.9. Prominent Trends
13. Europe Sterile Injectable Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis By Country
13.1.2. Y-o-Y Growth Projections By Country
13.2. Market Value Forecast By Molecules, 2024-2033
13.2.1. Large Molecules
13.2.2. Small Molecules
13.3. Market Value Forecast By Distribution Channel , 2024-2033
13.3.1. Hospitals Pharmacies
13.3.2. Retail Pharmacies
13.3.3. Online Pharmacies
13.4. Market Value Forecast By Drugs , 2024-2033
13.4.1. Monoclonal Antibodies (Mabs)
13.4.2. Cytokines
13.4.3. Insulin
13.4.4. Peptide Hormones
13.4.5. Vaccines
13.4.6. Immunoglobulins
13.4.7. Blood Factors
13.4.8. Peptide Antibiotics
13.4.9. Others
13.5. Market Value Forecast By Application, 2024-2033
13.5.1. Cancer
13.5.2. Diabetes
13.5.3. Cardiovascular Diseases
13.5.4. Musculoskeletal
13.5.5. CNS
13.5.6. Infections
13.5.7. Others
13.6. Market Value Forecast By Route of Administration, 2024-2033
13.6.1. Intravenous (IV)
13.6.2. Intramuscular (IM)
13.6.3. Subcutaneous (SC)
13.6.4. Others
13.7. Market Value Forecast By Country, 2024-2033
13.7.1. UK
13.7.2. France
13.7.3. Germany
13.7.4. Italy
13.7.5. Spain
13.7.6. Russia
13.7.7. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Molecules
13.8.2. By Distribution Channel
13.8.3. By Drugs
13.8.4. By Application
13.8.5. By Route of Administration
13.8.6. By Country
13.9. Prominent Trends
14. APEJ Sterile Injectable Drugs Market Analysis and Forecast
14.1. Introduction
14.1.1. Basis Point Share (BPS) Analysis By Country
14.1.2. Y-o-Y Growth Projections By Country
14.2. Market Value Forecast By Molecules, 2024-2033
14.2.1. Large Molecules
14.2.2. Small Molecules
14.3. Market Value Forecast By Distribution Channel , 2024-2033
14.3.1. Hospitals Pharmacies
14.3.2. Retail Pharmacies
14.3.3. Online Pharmacies
14.4. Market Value Forecast By Drugs , 2024-2033
14.4.1. Monoclonal Antibodies (Mabs)
14.4.2. Cytokines
14.4.3. Insulin
14.4.4. Peptide Hormones
14.4.5. Vaccines
14.4.6. Immunoglobulins
14.4.7. Blood Factors
14.4.8. Peptide Antibiotics
14.4.9. Others
14.5. Market Value Forecast By Application, 2024-2033
14.5.1. Cancer
14.5.2. Diabetes
14.5.3. Cardiovascular Diseases
14.5.4. Musculoskeletal
14.5.5. CNS
14.5.6. Infections
14.5.7. Others
14.6. Market Value Forecast By Route of Administration, 2024-2033
14.6.1. Intravenous (IV)
14.6.2. Intramuscular (IM)
14.6.3. Subcutaneous (SC)
14.6.4. Others
14.7. Market Value Forecast By Country, 2024-2033
14.7.1. Japan
14.7.2. China
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. ASEAN
14.7.6. Rest of APAC
14.8. Market Attractiveness Analysis
14.8.1. By Molecules
14.8.2. By Distribution Channel
14.8.3. By Drugs
14.8.4. By Application
14.8.5. By Route of Administration
14.8.6. By Country
14.9. Prominent Trends
15. MEA Sterile Injectable Drugs Market Analysis and Forecast
15.1. Introduction
15.1.1. Basis Point Share (BPS) Analysis By Country
15.1.2. Y-o-Y Growth Projections By Country
15.2. Market Value Forecast By Molecules, 2024-2033
15.2.1. Large Molecules
15.2.2. Small Molecules
15.3. Market Value Forecast By Distribution Channel , 2024-2033
15.3.1. Hospitals Pharmacies
15.3.2. Retail Pharmacies
15.3.3. Online Pharmacies
15.4. Market Value Forecast By Drugs , 2024-2033
15.4.1. Monoclonal Antibodies (Mabs)
15.4.2. Cytokines
15.4.3. Insulin
15.4.4. Peptide Hormones
15.4.5. Vaccines
15.4.6. Immunoglobulins
15.4.7. Blood Factors
15.4.8. Peptide Antibiotics
15.4.9. Others
15.5. Market Value Forecast By Application, 2024-2033
15.5.1. Cancer
15.5.2. Diabetes
15.5.3. Cardiovascular Diseases
15.5.4. Musculoskeletal
15.5.5. CNS
15.5.6. Infections
15.5.7. Others
15.6. Market Value Forecast By Route of Administration, 2024-2033
15.6.1. Intravenous (IV)
15.6.2. Intramuscular (IM)
15.6.3. Subcutaneous (SC)
15.6.4. Others
15.7. Market Value Forecast By Country, 2024-2033
15.7.1. GCC Countries
15.7.2. South Africa
15.7.3. North Africa
15.7.4. Rest of MEA
15.8. Market Attractiveness Analysis
15.8.1. By Molecules
15.8.2. By Distribution Channel
15.8.3. By Drugs
15.8.4. By Application
15.8.5. By Route of Administration
15.8.6. By Country
15.9. Prominent Trends
16. Competition Landscape
16.1. Competition Dashboard
16.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
